Clinical value of serum CA 125, CA 19 - 9 and CA 72 - 4 combined determination in diagnosis of ovary tumor
article
OA: closed
CC0
Abstract
Objective To explore the clinical value of serum CA125, CA19-9 and CA72-4 in ovary epithelial tumor and ovary endometriosis. Methods The detection results of ovary epithelial benign (n = 28) and malignant tumors (n = 15) and ovary endometriosis (n = 42) were retrospectively reviewed and compared with the results of 30 healthy women. Results The expression value of serum CA125 ,CA19-9 and CA72-4 in ovary epithelial cancers was obviously higher than others(all P <0.05). And the expression value of serum CA125 ,CA19-9 and CA72-4 in ovary endometriosis was higher than that of ovary benign tumors and the normal group (all P < 0.05). Positive rate of combined determination was higher than that of single marker(P <0.05). Conclusion The detection of serum CA125,CA19-9 and CA72-4 had great significance in the diagnosis of ovary epithelial cancers. It could also be used in the diagnosis of ovary endometriosis.
Key words:
Ovarian neoplasms; Tumor markers,biological
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK